• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcprocBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Proceedings
BMC Proc. 2009; 3(Suppl 6): S2.
Published online Aug 4, 2009. doi:  10.1186/1753-6561-3-S6-S2
PMCID: PMC2722095

A synopsis of eukaryotic Nα-terminal acetyltransferases: nomenclature, subunits and substrates

Abstract

We have introduced a consistent nomenclature for the various subunits of the NatA-NatE N-terminal acetyltransferases from yeast, humans and other eukaryotes.

Introduction

N-terminal acetylation has been extensively studied in yeast and humans and represents one of the most common protein modifications in eukaryotes, occurring on approximately 57% of yeast proteins and 84% human proteins [1], although it is rare in prokaryotes. Eukaryotic proteins initiate with methionine residues, which are cleaved from nascent chains if the penultimate residue has a radius of gyration of 1.29 Å or less [2]. N-terminal acetylation subsequently occurs on certain of the proteins, either containing or lacking the methionine residue, as depicted in Fig. Fig.1.1. The salient features of N-terminal acetylation are summarized in Table Table11 and Fig. Fig.2.2. Detailed reviews on the N-terminal acetyltransferases have appeared [3-7], and the N-terminal acetylation status of 742 human and 616 yeast protein N-termini have been compiled [1]. The wide range and diversity of substrates is due in part to the large number of different N-terminal acetylating enzymes, NatA-NatE. The sequence requirements for N-terminal acetylation vary with the N-terminal acetyltransferase. Only two amino acid residues, Met-Asn-, Met-Asp-, or Met-Glu-, are required for at least partial N-terminal acetylation by NatB [1,8]. On the other hand, 30 to 50 specific amino acids are required for N-terminal acetylation by NatD [9]. Each of the three major N-terminal acetyltransferases, NatA, NatB and NatC, contain a catalytic subunit, and one or two auxiliary subunits (Table (Table1).1). The sequence and functions of the yeast and human orthologous subunits are obviously related. A yeast ard1nat1-Δ strain was phenotypically complemented by hARD1 hNAT1, suggesting that yNatA and hNatA are similar. However, heterologous combinations, hARD1 yNAT1 and yARD1 hNAT1, were not functional in yeast, suggesting significant structural subunit differences between the species [1].

Table 1
Revised nomenclature for N-terminal acetyltransferases
Figure 1
A summary of the major pathways of N-terminal processing in eukaryotes, showing the four different termini. 1: Uncleaved and unacetylated Met-Xxx- N-termini; 2: Cleaved and unacetylated Xxx-N-termini; 3: Uncleaved and NatB/NatC acetylated Ac-Met-Xxx- ...
Figure 2
The major pathways of N-terminal processing in eukaryotes. Two methionine aminopeptidases (MAP), Map1p and Map2p, cleave N-terminal methionine residues that have small side chains (glycine, alanine, serine, cysteine, threonine, proline, and valine), although ...

Nomenclature

During a recent international meeting on N-terminal acetylation, it was pointed out that there is critical need to revise the gene symbols encoding the N-terminal acetyltransferases. The main reason for changing the nomenclature is so that each of the orthologous genes from different species would have the same name. Furthermore, orthologous genes were assigned not only by similarity of their sequences, but also by their action on the same set of proteins. Yeast NatA and human NatA were shown to acetylate the same set proteins by comparing a normal yeast strain with the mutant naa10naa15-ΔhNAA10 hNAA15 [1].

The use of the different symbols NAT, ARD, MDM, and MAK is confusing, and does not provide useful information, especially when applied to human NATs. We believe it can be misleading to assign a gene symbol based on one phenotype of a mutant when a large number of proteins are affected, and when the mutant is pleiotropic.

Most importantly, different orthologous genes should have different names. The symbols NAT1, NAT2 and NAT3 denote human genes encoding arylamine N-acetyltransferases, which are distinct from N-terminal acetyltransferases [10]. On the other hand, NCBI has designated the human homologue of the yeast NAT genes as follows: yNAT1 designated as hNARG1; yNAT3 designated as hNAT5; and yNAT5 designated as hNAT13. Also, ARD1 is used to describe the ADP-ribosylation factor domain protein 1 [11].

Therefore, in this paper we have introduced a new nomenclature for protein N-terminal acetyltransferases in eukaryotes (Table (Table1).1). It is important to note that NAA (Nα acetyltransferases) is not used to designate any other gene in yeast or higher eukaryotes. We have assigned each of the subunits of the NatA-NatE complexes a Naa symbol, as presented in Table Table1.1. We have also recommended a nomenclature for paralogs of human NatA complexes containing either Naa10p or Naa11p in combination with either Naa15p or Naa16p (Table (Table2).2). The revised symbols, along with synonyms from yeast and humans, are presented in Table Table3.3. Clearly, this revised nomenclature will greatly diminish the confusion in describing orthologous subunits from different species.

Table 2
Paralogs
Table 3
Synonyms

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors wrote the manuscript and approved the final version.

Acknowledgements

This work was supported by the Norwegian Health region West (to T.A.), the Norwegian Research Council (to T.A), and the National Institutes of Health Grant R01 GM12702 (to F.S.).

This article has been published as part of BMC Proceedings Volume 3 Supplement 6, 2009: Proceedings of the 2007 and 2008 Symposia on Protein N-terminal Acetylation. The full contents of the supplement are available online at http://www.biomedcentral.com/1753-6561/3?issue=S6

References

  • Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci USA. 2009;106:8157–8162. doi: 10.1073/pnas.0901931106. [PMC free article] [PubMed] [Cross Ref]
  • Sherman F, Stewart JW, Tsunasawa S. Methionine or not methionine at the beginning of a protein. Bioessays. 1985;3:27–31. doi: 10.1002/bies.950030108. [PubMed] [Cross Ref]
  • Arnesen T, Thompson PR, Varhaug JE, Lillehaug JR. The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target? Curr Cancer Drug Targets. 2008;8:545–553. doi: 10.2174/156800908786241113. [PubMed] [Cross Ref]
  • Gromyko D, Starheim KK, Velde R, Varhaug JE, Arnesen T. Human N-terminal acetyltransferases: Identification and biological significance. BMC Proc. 2009;3:S3. doi: 10.1186/1753-6561-3-s3-o3. [PMC free article] [PubMed] [Cross Ref]
  • Polevoda B, Norbeck J, Takakura H, Blomberg A, Sherman F. Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae. EMBO J. 1999;18:6155–6168. doi: 10.1093/emboj/18.21.6155. [PMC free article] [PubMed] [Cross Ref]
  • Polevoda B, Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol. 2003;325:595–622. doi: 10.1016/S0022-2836(02)01269-X. [PubMed] [Cross Ref]
  • Polevoda B, Sherman F. Composition and function of the eukaryotic N-terminal acetyltransferase subunits. Biochemical and Biophysical Research Communications. 2003;308:1–11. doi: 10.1016/S0006-291X(03)01316-0. [PubMed] [Cross Ref]
  • Polevoda B, Cardillo TS, Doyle TC, Bedi GS, Sherman F. Nat3p and Mdm20p are required for function of yeast NatB Nalpha-terminal acetyltransferase and of actin and tropomyosin. J Biol Chem. 2003;278:30686–30697. doi: 10.1074/jbc.M304690200. [PubMed] [Cross Ref]
  • Polevoda B, Hoskins J, Sherman F. Properties of Nat4, an N{alpha}-Acetyltransferase of Saccharomyces cerevisae that Modifies N termini of Histones H2A and H4. Mol Cell Biol. 2009 [PMC free article] [PubMed]
  • Vagena E, Fakis G, Boukouvala S. Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases. Curr Drug Metab. 2008;9:628–660. doi: 10.2174/138920008785821729. [PubMed] [Cross Ref]
  • Vichi A, Payne DM, Pacheco-Rodriguez G, Moss J, Vaughan M. E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1) Proc Natl Acad Sci USA. 2005;102:1945–1950. doi: 10.1073/pnas.0409800102. [PMC free article] [PubMed] [Cross Ref]
  • Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE, Lillehaug JR. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J. 2005;386:433–443. doi: 10.1042/BJ20041071. [PMC free article] [PubMed] [Cross Ref]
  • Tribioli C, Mancini M, Plassart E, Bione S, Rivella S, Sala C, et al. Isolation of new genes in distal Xq28: transcriptional map and identification of a human homologue of the ARD1 N-acetyl transferase of Saccharomyces cerevisiae. Hum Mol Genet. 1994;3:1061–1067. doi: 10.1093/hmg/3.7.1061. [PubMed] [Cross Ref]
  • Whiteway M, Szostak JW. The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell. 1985;43:483–492. doi: 10.1016/0092-8674(85)90178-3. [PubMed] [Cross Ref]
  • Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, et al. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase. BMC Biochem. 2006;7:13. doi: 10.1186/1471-2091-7-13. [PMC free article] [PubMed] [Cross Ref]
  • Fluge O, Bruland O, Akslen LA, Varhaug JE, Lillehaug JR. NATH, a novel gene overexpressed in papillary thyroid carcinomas. Oncogene. 2002;21:5056–5068. doi: 10.1038/sj.onc.1205687. [PubMed] [Cross Ref]
  • Gendron RL, Adams LC, Paradis H. Tubedown-1, a novel acetyltransferase associated with blood vessel development. Dev Dyn. 2000;218:300–315. doi: 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K. [PubMed] [Cross Ref]
  • Mullen JR, Kayne PS, Moerschell RP, Tsunasawa S, Gribskov M, Colavito-Shepanski M, et al. Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J. 1989;8:2067–2075. [PMC free article] [PubMed]
  • Park EC, Szostak JW. ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J. 1992;11:2087–2093. [PMC free article] [PubMed]
  • Sugiura N, Adams SM, Corriveau RA. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J Biol Chem. 2003;278:40113–40120. doi: 10.1074/jbc.M301218200. [PubMed] [Cross Ref]
  • Arnesen T, Gromyko D, Kagabo D, Betts MJ, Starheim KK, Varhaug JE, et al. A novel human NatA N-alpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1) BMC Biochem. 2009;10:15. doi: 10.1186/1471-2091-10-15. [PMC free article] [PubMed] [Cross Ref]
  • Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R. Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene. 2008;27:7296–7306. doi: 10.1038/onc.2008.332. [PubMed] [Cross Ref]
  • Starheim KK, Arnesen T, Gromyko D, Ryningen A, Varhaug JE, Lillehaug JR. Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression. Biochem J. 2008;415:325–331. doi: 10.1042/BJ20080658. [PubMed] [Cross Ref]
  • Polevoda B, Sherman F. NatC Nalpha-terminal acetyltransferase of yeast contains three subunits, Mak3p, Mak10p, and Mak31p. J Biol Chem. 2001;276:20154–20159. doi: 10.1074/jbc.M011440200. [PubMed] [Cross Ref]
  • Starheim KK, Gromyko D, Evjenth R, Ryningen A, Varhaug JE, Lillehaug JR, et al. Knockdown of the Human N{alpha}-Terminal Acetyltransferase Complex C (hNatC) Leads to p53-Dependent Apoptosis and Aberrant hArl8b Localization. Mol Cell Biol. 2009;29:3569–3581. doi: 10.1128/MCB.01909-08. [PMC free article] [PubMed] [Cross Ref]
  • Tercero JC, Wickner RB. MAK3 encodes an N-acetyltransferase whose modification of the L-A gag NH2 terminus is necessary for virus particle assembly. J Biol Chem. 1992;267:20277–20281. [PubMed]
  • Wenzlau JM, Garl PJ, Simpson P, Stenmark KR, West J, Artinger KB, et al. Embryonic growth-associated protein is one subunit of a novel N-terminal acetyltransferase complex essential for embryonic vascular development. Circ Res. 2006;98:846–855. doi: 10.1161/01.RES.0000214539.86593.7a. [PubMed] [Cross Ref]
  • Song OK, Wang X, Waterborg JH, Sternglanz R. An Nalpha-acetyltransferase responsible for acetylation of the N-terminal residues of histones H4 and H2A. J Biol Chem. 2003;278:38109–38112. doi: 10.1074/jbc.C300355200. [PubMed] [Cross Ref]
  • Arnesen T, Anderson D, Torsvik J, Halseth HB, Varhaug JE, Lillehaug JR. Cloning and characterization of hNAT5/hSAN: an evolutionarily conserved component of the NatA protein N-alpha-acetyltransferase complex. Gene. 2006;371:291–295. doi: 10.1016/j.gene.2005.12.008. [PubMed] [Cross Ref]
  • Gautschi M, Just S, Mun A, Ross S, Rucknagel P, Dubaquie Y, et al. The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol. 2003;23:7403–7414. doi: 10.1128/MCB.23.20.7403-7414.2003. [PMC free article] [PubMed] [Cross Ref]
  • Williams BC, Garrett-Engele CM, Li Z, Williams EV, Rosenman ED, Goldberg ML. Two putative acetyltransferases, san and deco, are required for establishing sister chromatid cohesion in Drosophila. Curr Biol. 2003;13:2025–2036. doi: 10.1016/j.cub.2003.11.018. [PubMed] [Cross Ref]

Articles from BMC Proceedings are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links